<DOC>
	<DOCNO>NCT00533637</DOCNO>
	<brief_summary>Evaluation NLA Nasal Spray regard taste perversion local tolerance</brief_summary>
	<brief_title>Taste Local Tolerance Study NLA Nasal Spray Patients With Allergic Rhinitis</brief_title>
	<detailed_description>Oral intranasal antihistamine first line treatment allergic rhinitis . Cetirizine second-generation selective antihistamine widely use oral formulation treatment allergic rhinitis . Local administration cetirizine show reduce symptom allergen challenge , potential shorten time onset decrease systemic side effect . However , local irritation nasal burning/pain report nasal administration . For compliance patient take nasal spray , taste tolerance product particular importance . NLA Nasal Spray contain cetirizine liposomal formulation aim improve tolerability . The present study aim compare NLA Nasal Spray cetirizine aqueous formulation placebo regard taste perversion local tolerance . This investigated off-season patient seasonal allergic rhinitis provocation allergen .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>18 50 year age ( inclusive ) Body Mass Index ( BMI ) 18 28 kg/m2 History polleninduced seasonal allergic rhinitis least two year otherwise healthy Elevated specific IgE least one aero allergen least one positive skin pick test ( SPT ) Seasonal allergic rhinitis symptom provoke allergen correspond elevate specific IgE positive SPT Signed write Informed Consent Perennial allergic rhinitis except cat and/or dog sensitivity condition patient expose cat dog Soy bean allergy Peanut allergy Smoking last month study inclusion Any upper respiratory tract infection period 2 week start study Chronic medication Any medication , include herbal medicine , last five halflives ( tÂ½ ) Nasal anatomical deviation Extensive use nasal spray judge Investigator Ongoing nasal symptom judge Investigator Known hypersensitivity cetirizine Pregnant breastfeed woman Fertile woman use reliable method contraception ( i.e . IUD , barrier method , hormonal contraceptive , abstinence ) Participation investigational study last three month Inability adhere study plan Previous inclusion study Blood donation last three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Nasal spray</keyword>
	<keyword>Anti-histamine</keyword>
	<keyword>Tolerability</keyword>
</DOC>